Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer

J Infect Dis. 2011 Mar 15;203(6):814-22. doi: 10.1093/infdis/jiq116.

Abstract

Background: Detailed descriptions of long-term persistence of human papillomavirus (HPV) in the absence of cervical precancer are lacking.

Methods: In a large, population-based natural study conducted in Guanacaste, Costa Rica, we studied a subset of 810 initially HPV-positive women with ≥ 3 years of active follow-up with ≥ 3 screening visits who had no future evidence of cervical precancer. Cervical specimens were tested for >40 HPV genotypes using a MY09/11 L1-targeted polymerase chain reaction method.

Results: Seventy-two prevalently-detected HPV infections (5%) in 58 women (7%) persisted until the end of the follow-up period (median duration of follow-up, 7 years) without evidence of cervical precancer. At enrollment, women with long-term persistence were more likely to have multiple prevalently-detected HPV infections (P < .001) than were women who cleared their baseline HPV infections during follow-up. In a logistic regression model, women with long-term persistence were more likely than women who cleared infections to have another newly-detected HPV infection detectable at ≥ 3 visits (odds ratio, 2.6; 95% confidence interval, 1.2-5.6).

Conclusions: Women with long-term persistence of HPV infection appear to be generally more susceptible to other HPV infections, especially longer-lasting infections, than are women who cleared their HPV infections.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Adult
  • Aged
  • Alphapapillomavirus / genetics
  • Alphapapillomavirus / pathogenicity*
  • Cervix Uteri / virology
  • Costa Rica / epidemiology
  • Female
  • Follow-Up Studies
  • Genotype
  • Humans
  • Logistic Models
  • Middle Aged
  • Papillomavirus Infections / epidemiology*
  • Papillomavirus Infections / virology
  • Polymerase Chain Reaction
  • Precancerous Conditions / virology
  • Risk Factors
  • Uterine Cervical Neoplasms / virology
  • Vaginal Smears